{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:47:55Z","timestamp":1786978075535,"version":"build-2736575974"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":99,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL145528"],"award-info":[{"award-number":["R01HL145528"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R35HL139599"],"award-info":[{"award-number":["R35HL139599"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL007910"],"award-info":[{"award-number":["T32HL007910"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21AR059278"],"award-info":[{"award-number":["R21AR059278"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F31DK122679"],"award-info":[{"award-number":["F31DK122679"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK112958"],"award-info":[{"award-number":["R01DK112958"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U54DK106846"],"award-info":[{"award-number":["U54DK106846"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL145528"],"award-info":[{"award-number":["R01HL145528"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R35HL139599"],"award-info":[{"award-number":["R35HL139599"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL007910"],"award-info":[{"award-number":["T32HL007910"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21AR059278"],"award-info":[{"award-number":["R21AR059278"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F31DK122679"],"award-info":[{"award-number":["F31DK122679"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK112958"],"award-info":[{"award-number":["R01DK112958"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U54DK106846"],"award-info":[{"award-number":["U54DK106846"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Fibroblast growth factor-23 (FGF23) is a critical factor in chronic kidney disease (CKD), with elevated levels causing alterations in mineral metabolism and increased odds for mortality. Patients with CKD develop anemia as the kidneys progressively lose the ability to produce erythropoietin (EPO). Anemia is a potent driver of FGF23 secretion; therefore, a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) currently in clinical trials to elevate endogenous EPO to resolve anemia was tested for effects on iron utilization and FGF23-related parameters in a CKD mouse model. Mice were fed either a casein control diet or an adenine-containing diet to induce CKD. The CKD mice had markedly elevated iFGF23 and blood urea nitrogen (BUN), hyperphosphatemia, and anemia. Cohorts of mice were then treated with a patient-equivalent dose of BAY 85-3934 (BAY; Molidustat), which elevated EPO and completely resolved aberrant complete blood counts (CBCs) in the CKD mice. iFGF23 was elevated in vehicle-treated CKD mice (120-fold), whereas circulating iFGF23 was significantly attenuated (&amp;gt;60%) in the BAY-treated CKD mice. The BAY-treated mice with CKD also had reduced BUN, but there was no effect on renal vitamin D metabolic enzyme expression. Consistent with increased EPO, bone marrow Erfe, Transferrin receptor (Tfrc), and EpoR mRNAs were increased in BAY-treated CKD mice, and in vitro hypoxic marrow cultures increased FGF23 with direct EPO treatment. Liver Bmp-6 and hepcidin expression were downregulated in all BAY-treated groups. Femur trabecular parameters and cortical porosity were not worsened with BAY administration. In vitro, differentiated osteocyte-like cells exposed to an iron chelator to simulate iron depletion\/hypoxia increased FGF23; repletion with holo-transferrin completely suppressed FGF23 and normalized Tfrc1. Collectively, these results support that resolving anemia using a HIF-PHI during CKD was associated with lower BUN and reduced FGF23, potentially through direct restoration of iron utilization, thus providing modifiable outcomes beyond improving anemia for this patient population. \u00a9 2021 American Society for Bone and Mineral Research (ASBMR).<\/jats:p>","DOI":"10.1002\/jbmr.4272","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T07:15:48Z","timestamp":1613546148000},"page":"1117-1130","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse Model"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1763-1867","authenticated-orcid":false,"given":"Megan L","family":"Noonan","sequence":"first","affiliation":[{"name":"Department of Medical and Molecular Genetics Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafiou","family":"Agoro","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer A","family":"Sacks","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Cell Biology, and Physiology Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"Swallow","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Cell Biology, and Physiology Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6687-1106","authenticated-orcid":false,"given":"Erica L","family":"Clinkenbeard","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maegan L","family":"Capitano","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Prideaux","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Cell Biology, and Physiology Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J","family":"Atkins","sequence":"additional","affiliation":[{"name":"Centre for Orthopaedic and Trauma Research The University of Adelaide Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-585X","authenticated-orcid":false,"given":"William R","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Cell Biology, and Physiology Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1174-9004","authenticated-orcid":false,"given":"Matthew R","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology Indiana University School of Medicine Indianapolis IN"},{"name":"Department of Anatomy, Cell Biology, and Physiology Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal E","family":"Broxmeyer","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E","family":"White","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology Indiana University School of Medicine Indianapolis IN"},{"name":"Department of Medical and Molecular Genetics Indiana University School of Medicine Indianapolis IN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"issue":"1","key":"2024012713481538500_jbmr4272-bib-0001","doi-asserted-by":"crossref","first-page":"e84943","DOI":"10.1371\/journal.pone.0084943","article-title":"Prevalence of anemia in chronic kidney disease in the United States","volume":"9","author":"Stauffer","year":"2014","journal-title":"PLoS One."},{"issue":"3","key":"2024012713481538500_jbmr4272-bib-0002","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1681\/ASN.V103610","article-title":"Hematocrit level and associated mortality in hemodialysis patients","volume":"10","author":"Ma","year":"1999","journal-title":"J Am Soc Nephrol."},{"issue":"46","key":"2024012713481538500_jbmr4272-bib-0003","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2024012713481538500_jbmr4272-bib-0004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int."},{"issue":"4","key":"2024012713481538500_jbmr4272-bib-0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest."},{"issue":"3","key":"2024012713481538500_jbmr4272-bib-0006","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res."},{"issue":"12","key":"2024012713481538500_jbmr4272-bib-0007","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology."},{"issue":"5","key":"2024012713481538500_jbmr4272-bib-0008","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol."},{"issue":"23","key":"2024012713481538500_jbmr4272-bib-0009","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA."},{"issue":"1","key":"2024012713481538500_jbmr4272-bib-0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, fibroblast growth Factor-23, and cardiovascular disease in hemodialysis: the evaluation of Cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial","volume":"132","author":"Moe","year":"2015","journal-title":"Circulation."},{"key":"2024012713481538500_jbmr4272-bib-0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.123817","article-title":"Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD","volume":"4","author":"Clinkenbeard","year":"2019","journal-title":"JCI Insight"},{"issue":"7","key":"2024012713481538500_jbmr4272-bib-0012","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest."},{"issue":"2\u20133","key":"2024012713481538500_jbmr4272-bib-0013","first-page":"287","article-title":"Factors that regulate extrarenal erythropoietin production","volume":"10","author":"Fried","year":"1984","journal-title":"Blood Cells."},{"issue":"6","key":"2024012713481538500_jbmr4272-bib-0014","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1053\/j.ajkd.2016.12.011","article-title":"Hypoxia-inducible factor Prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients with CKD","volume":"69","author":"Gupta","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"2024012713481538500_jbmr4272-bib-0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneph.2015.193","article-title":"HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond","volume":"12","author":"Maxwell","year":"2016","journal-title":"Nat Rev Nephrol."},{"issue":"20","key":"2024012713481538500_jbmr4272-bib-0016","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N Engl J Med."},{"issue":"Suppl 1","key":"2024012713481538500_jbmr4272-bib-0017","first-page":"S110","article-title":"HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism","volume":"21","author":"Haase","year":"2017","journal-title":"Hemodial Int."},{"issue":"4","key":"2024012713481538500_jbmr4272-bib-0018","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000502012","article-title":"Iron regulation by Molidustat, a daily oral hypoxia-inducible factor Prolyl hydroxylase inhibitor, in patients with chronic kidney disease","volume":"143","author":"Akizawa","year":"2019","journal-title":"Nephron."},{"issue":"11","key":"2024012713481538500_jbmr4272-bib-0019","doi-asserted-by":"crossref","first-page":"e111838","DOI":"10.1371\/journal.pone.0111838","article-title":"Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects","volume":"9","author":"Flamme","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2024012713481538500_jbmr4272-bib-0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2215\/CJN.02510218","article-title":"Effects of Molidustat in the treatment of anemia in CKD","volume":"14","author":"Macdougall","year":"2019","journal-title":"Clin J Am Soc Nephrol."},{"issue":"11","key":"2024012713481538500_jbmr4272-bib-0021","doi-asserted-by":"crossref","first-page":"e14434","DOI":"10.14814\/phy2.14434","article-title":"Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)","volume":"8","author":"Noonan","year":"2020","journal-title":"Physiol Rep."},{"key":"2024012713481538500_jbmr4272-bib-0022","doi-asserted-by":"crossref","first-page":"105020","DOI":"10.1016\/j.phrs.2020.105020","article-title":"Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: a network meta-analysis","volume":"159","author":"Zheng","year":"2020","journal-title":"Pharmacol Res."},{"issue":"6","key":"2024012713481538500_jbmr4272-bib-0023","doi-asserted-by":"crossref","first-page":"e026602","DOI":"10.1136\/bmjopen-2018-026602","article-title":"Molidustat for the treatment of renal anaemia in patients with dialysis-dependent chronic kidney disease: design and rationale of three phase III studies","volume":"9","author":"Akizawa","year":"2019","journal-title":"BMJ Open."},{"key":"2024012713481538500_jbmr4272-bib-0024","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/boneres.2016.11","article-title":"The hypoxia-inducible factor-1alpha activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia","volume":"4","author":"Zhang","year":"2016","journal-title":"Bone Res."},{"issue":"4","key":"2024012713481538500_jbmr4272-bib-0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.ackd.2019.04.004","article-title":"Hypoxia-inducible factor activators in renal anemia: current clinical experience","volume":"26","author":"Sanghani","year":"2019","journal-title":"Adv Chronic Kidney Dis."},{"issue":"1","key":"2024012713481538500_jbmr4272-bib-0026","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"J Appl Toxicol."},{"issue":"11","key":"2024012713481538500_jbmr4272-bib-0027","doi-asserted-by":"crossref","first-page":"F1169","DOI":"10.1152\/ajprenal.00676.2013","article-title":"Gender differences in adenine-induced chronic kidney disease and cardiovascular complications in rats","volume":"307","author":"Diwan","year":"2014","journal-title":"Am J Physiol Renal Physiol."},{"issue":"2","key":"2024012713481538500_jbmr4272-bib-0028","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm."},{"key":"2024012713481538500_jbmr4272-bib-0029","first-page":"11.19.385138","article-title":"Generation of two multipotent mesenchymal progenitor cell lines capable of osteogenic, mature osteocyte, adipogenic, and chondrogenic differentiation","volume":"2020","author":"Prideaux","year":"2020","journal-title":"bioRxiv."},{"issue":"12","key":"2024012713481538500_jbmr4272-bib-0030","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3324\/haematol.2016.144808","article-title":"Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors","volume":"101","author":"Baschant","year":"2016","journal-title":"Haematologica."},{"issue":"7","key":"2024012713481538500_jbmr4272-bib-0031","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.cell.2015.04.054","article-title":"Enhancing hematopoietic stem cell transplantation efficacy by mitigating oxygen shock","volume":"161","author":"Mantel","year":"2015","journal-title":"Cell."},{"issue":"4","key":"2024012713481538500_jbmr4272-bib-0032","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods."},{"issue":"7","key":"2024012713481538500_jbmr4272-bib-0033","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"7","key":"2024012713481538500_jbmr4272-bib-0034","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat Genet."},{"issue":"11","key":"2024012713481538500_jbmr4272-bib-0035","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.3324\/haematol.2017.167882","article-title":"Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow","volume":"102","author":"Clinkenbeard","year":"2017","journal-title":"Haematologica."},{"issue":"12","key":"2024012713481538500_jbmr4272-bib-0036","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/ndt\/gfy189","article-title":"Effects of erythropoietin on fibroblast growth factor 23 in mice and humans","volume":"34","author":"Hanudel","year":"2019","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"2024012713481538500_jbmr4272-bib-0037","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"8","key":"2024012713481538500_jbmr4272-bib-0038","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","author":"Nickolas","year":"2013","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2024012713481538500_jbmr4272-bib-0039","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11914-017-0366-z","article-title":"Bone quality in chronic kidney disease: definitions and diagnostics","volume":"15","author":"McNerny","year":"2017","journal-title":"Curr Osteoporos Rep."},{"key":"2024012713481538500_jbmr4272-bib-0040","doi-asserted-by":"crossref","first-page":"11049","DOI":"10.1038\/srep11049","article-title":"Osteocyte specific responses to soluble and mechanical stimuli in a stem cell derived culture model","volume":"5","author":"Thompson","year":"2015","journal-title":"Sci Rep."},{"issue":"12","key":"2024012713481538500_jbmr4272-bib-0041","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.2215\/CJN.07851109","article-title":"Association between clinical risk factors and progression of chronic kidney disease in children","volume":"5","author":"Staples","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"issue":"20","key":"2024012713481538500_jbmr4272-bib-0042","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med."},{"issue":"2","key":"2024012713481538500_jbmr4272-bib-0043","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbmr.2049","article-title":"Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice","volume":"29","author":"Clinkenbeard","year":"2014","journal-title":"J Bone Miner Res."},{"issue":"15","key":"2024012713481538500_jbmr4272-bib-0044","doi-asserted-by":"crossref","first-page":"e137062","DOI":"10.1172\/jci.insight.137062","article-title":"Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes","volume":"5","author":"Weidner","year":"2020","journal-title":"JCI Insight."},{"issue":"10","key":"2024012713481538500_jbmr4272-bib-0045","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00424-018-2171-7","article-title":"Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men","volume":"470","author":"Daryadel","year":"2018","journal-title":"Pflugers Arch."},{"issue":"3","key":"2024012713481538500_jbmr4272-bib-0046","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000455166","article-title":"Targeting hypoxia-inducible factors for the treatment of anemia in chronic kidney disease patients","volume":"45","author":"Locatelli","year":"2017","journal-title":"Am J Nephrol."},{"issue":"7","key":"2024012713481538500_jbmr4272-bib-0047","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/bcp.13584","article-title":"First-in-man-proof of concept study with molidustat: a novel selective oral HIF-prolyl hydroxylase inhibitor for the treatment of renal anaemia","volume":"84","author":"Bottcher","year":"2018","journal-title":"Br J Clin Pharmacol."},{"issue":"6","key":"2024012713481538500_jbmr4272-bib-0048","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.dmpk.2015.08.004","article-title":"Pharmacokinetics, pharmacodynamics and safety of single, oral doses of GSK1278863, a novel HIF-prolyl hydroxylase inhibitor, in healthy Japanese and Caucasian subjects","volume":"30","author":"Hara","year":"2015","journal-title":"Drug Metab Pharmacokinet."},{"issue":"6","key":"2024012713481538500_jbmr4272-bib-0049","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.kint.2019.07.026","article-title":"Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease","volume":"96","author":"Francis","year":"2019","journal-title":"Kidney Int."},{"issue":"5","key":"2024012713481538500_jbmr4272-bib-0050","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.kint.2017.11.018","article-title":"Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury","volume":"93","author":"Toro","year":"2018","journal-title":"Kidney Int."},{"issue":"11","key":"2024012713481538500_jbmr4272-bib-0051","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2024012713481538500_jbmr4272-bib-0052","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jbmr.3878","article-title":"Oral iron replacement normalizes fibroblast growth factor 23 in iron-deficient patients with autosomal dominant hypophosphatemic rickets","volume":"35","author":"Imel","year":"2020","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2024012713481538500_jbmr4272-bib-0053","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA."},{"key":"2024012713481538500_jbmr4272-bib-0054","doi-asserted-by":"crossref","first-page":"bcr2017222851","DOI":"10.1136\/bcr-2017-222851","article-title":"Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration","volume":"2018","author":"Klein","year":"2018","journal-title":"BMJ Case Rep."},{"issue":"8","key":"2024012713481538500_jbmr4272-bib-0055","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J Bone Miner Res."},{"key":"2024012713481538500_jbmr4272-bib-0056","author":"Abu-Zaid A, Magzoub D, Aldehami MA, Behiry AA, Bhagavathula AS, Hajji R.","journal-title":"Biol Trace Elem Res."},{"issue":"3","key":"2024012713481538500_jbmr4272-bib-0057","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jphs.2019.12.002","article-title":"Effects of orally active hypoxia inducible factor alpha prolyl hydroxylase inhibitor FG4592 on renal fibrogenic potential in mouse unilateral ureteral obstruction model","volume":"142","author":"Kabei","year":"2020","journal-title":"J Pharmacol Sci."},{"issue":"2","key":"2024012713481538500_jbmr4272-bib-0058","doi-asserted-by":"crossref","first-page":"F388","DOI":"10.1152\/ajprenal.00419.2019","article-title":"Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease","volume":"318","author":"Uchida","year":"2020","journal-title":"Am J Physiol Renal Physiol."},{"issue":"4","key":"2024012713481538500_jbmr4272-bib-0059","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jphs.2020.09.004","article-title":"Effects of post-renal anemia treatment with the HIF-PHD inhibitor molidustat on adenine-induced renal anemia and kidney disease in mice","volume":"144","author":"Li","year":"2020","journal-title":"J Pharmacol Sci."},{"issue":"5","key":"2024012713481538500_jbmr4272-bib-0060","doi-asserted-by":"crossref","first-page":"F877","DOI":"10.1152\/ajprenal.00089.2016","article-title":"Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease","volume":"311","author":"Akchurin","year":"2016","journal-title":"Am J Physiol Renal Physiol."},{"issue":"3","key":"2024012713481538500_jbmr4272-bib-0061","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/ndt\/gfi273","article-title":"Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia","volume":"21","author":"Tamagaki","year":"2006","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"2024012713481538500_jbmr4272-bib-0062","doi-asserted-by":"crossref","first-page":"e1015","DOI":"10.1210\/clinem\/dgz309","article-title":"Iron overload associated endocrine dysfunction leading to lower bone mineral density in thalassemia major","volume":"105","author":"Yang","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2024012713481538500_jbmr4272-bib-0063","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.kint.2020.05.043","article-title":"Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney disease","volume":"98","author":"Patino","year":"2020","journal-title":"Kidney Int."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.4272","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.4272","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/36\/6\/1117\/55456290\/jbmr4272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/36\/6\/1117\/55456290\/jbmr4272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:06:54Z","timestamp":1710328014000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/36\/6\/1117-1130\/7516596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":63,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,2,16]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4272","relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBMR.4272\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.739568161.793583075","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4272\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4272\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4272\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4272\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4272\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4272\/v2\/review1","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2020-10-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}